NPI: 1619535119 · HANOVER, PA 17331 · Nurse Practitioner · NPI assigned 05/31/2019
Authorized official MARKLEY, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | MARKLEY, CHRISTOPHER (SENIOR VP) |
| NPI Enumeration Date | 05/31/2019 |
Other providers sharing the same authorized official: MARKLEY, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 14 | $864.50 |
| 2022 | 790 | $25K |
| 2023 | 19,020 | $618K |
| 2024 | 16,498 | $592K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19,879 | 19,184 | $767K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,731 | 4,595 | $280K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,335 | 1,298 | $80K |
| 87428 | 2,216 | 2,137 | $39K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,024 | 3,909 | $28K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 503 | 494 | $14K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 38 | 38 | $5K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 42 | 36 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 129 | 127 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 420 | 409 | $4K |
| 81003 | 984 | 947 | $3K | |
| 81025 | 526 | 506 | $2K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14 | 14 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 31 | 31 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 70 | 67 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 29 | 29 | $731.01 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 16 | 15 | $609.50 |
| 90715 | 12 | 12 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 389 | 371 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 61 | 61 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 146 | 143 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 641 | 623 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 86 | 84 | $0.00 |